FDA NDC Directory · JSON-LD · Markdown

OCREVUS

NDC 50242-150 · HUMAN PRESCRIPTION DRUG · INJECTION

Generic nameocrelizumab
Labeler / ManufacturerGenentech, Inc.
Marketing categoryBiologic License Application · App BLA761053
Dosage form / routeINJECTION · INTRAVENOUS
Active ingredientsOCRELIZUMAB (300 mg/10mL)
Marketing started20170328
Package count1

External sources

Source: openFDA. Public-domain (CC0).